Reducing Deaths from ACLF is a Realistic Goal

Written By: user Dr. Rajiv Jalan
Published On: 05 Aug, 2023 2:33 PM | Updated On: 05 Aug, 2023 2:37 PM

Reducing Deaths from ACLF is a Realistic Goal

  • Patients with acute decompensated cirrhosis have high morbidity/ mortality.
  • Liver transplantation can save the lives of patients with acute-onchronic liver failure (ACLF).
  • New therapies are under development for managing ACLF, like CARBALIVE, PRECIOSA, TLR4 antagonist, G-TAK, DIALIVE APACHE.
  • Cirrhocare is a decompensated cirrhosis management in the community that provides early diagnosis, allows rapid intervention and reduces hospitalization; thus improving the quality of life.
  • CARBALIVE are adsorbent beads whose unique physical structure gives functionality to remove macromolecules such as endotoxins which reduce inflammation and improves gut health. 
  • DIALIVE modifies the pathophysiological process involved in the pathogenesis of ACLF.Patients with acute decompensated cirrhosis have high morbidity/ mortality.
  • Liver transplantation can save the lives of patients with acute-onchronic liver failure (ACLF).
  • New therapies are under development for managing ACLF, like CARBALIVE, PRECIOSA, TLR4 antagonist, G-TAK, DIALIVE APACHE.
  • Cirrhocare is a decompensated cirrhosis management in the community that provides early diagnosis, allows rapid intervention and reduces hospitalization; thus improving the quality of life.
  • CARBALIVE are adsorbent beads whose unique physical structure gives functionality to remove macromolecules such as endotoxins which reduce inflammation and improves gut health.
  • DIALIVE modifies the pathophysiological process involved in the pathogenesis of ACLF.

user
Dr. Rajiv Jalan

Professor Rajiv Jalan is a leading consultant hepatologist with more than 30 years of experience. Professor Jalan has been a professor of hepatology at University College London since 2000 and has lead research on multiple areas of liver disease, and is at the forefront of research into liver failure. Recently Professor Jalan was part of a team who invented the DIALIVE - a new liver dialysis system being trialled at the Royal Free Hospital where he is a consultant hepatologist and head of the liver failure laboratory. He did is MBBS (Clinical Medicine) in 1986 and MD (Hepatology) from Edinburgh University in 1993-2000 and PhD (Medicine) from Maastricht University in 1998-2005.

Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks